期刊文献+

同系与异系移植MMP_s、TIMP_s表达的比较实验研究 被引量:1

Investigation of the expressions of MMP_s and TIMP_s in rat transplantation arteriosclerosis model of Chronic Rejection
下载PDF
导出
摘要 目的:动态观察MMPs、TIMPs在移植动脉中的表达规律,探讨其在移植动脉硬化中的作用。方法:将Wistar大鼠120只、SD大鼠40只随机分为10组,异系(SDWistar)移植组和同系(WistarWistar)移植组各5组,分别于术后3d和1、2、4、8w采取。形态学观察、免疫组织化学SP染色法测定移植段腹主动脉内MMP1、TIMP1,3的表达、Northern杂交定量分析MMP2表达,并加以比较。结果:①术后2~8w异系移植组移植段腹主动脉内膜厚度较同系移植组显著增生(P<0.05)。②同系移植组MMP1,2和TIMP1较低,峰值均出现于术后2~4w;异系移植组表达显著增加,MMP1,2峰值出现于术后第2w,TIMP1峰值出现于术后第4w。③TIMP3在各组中表达均较低,仅见于细胞外基质中。结论:移植时慢性排斥反应过程中MMPs/TIMPs表达时象及量效的不平衡导致了细胞外基质合成与降解的失衡,是移植物的动脉硬化发生的重要原因。 Objcetive : To dynamic observe the rule of the expressions of MMPs and TIMPs on the transplanted artery, Which is for discussing these functions of transplanted arteriosclerosis. Methods:The expressions of MMPs and TIMPs in the tissues of transplanted abdominal aorta were mensurated by morphology, immunohistochemical SP staining method and the expression of MMp-2 was detected by Northern blot quantltatlve analysis in abdominal aortic orthotopic transplantation modal. Results : The thickness of tunica intima of the allografts was much evidently thicker than isografts 2 Weeks after transplantation(P 〈 0. 05). The expresses of MMPs and TIMPs In the isografts came to the highest on 14th day and then declined.But the expressions of MMPs and TIMPs In the allografts were observably higher tgan the former,and the beak of the expression of TIMP-1 was prolonged to 4th week. TIMP-3 Kept lowly expressed In every groups. Conclusion : The unbalance of expressions of MMPs/TIMPs leading to the turbulence Of synthesization and degradation ECM,is an important reason for the process of chronic rejection.
出处 《中国现代普通外科进展》 CAS 2005年第4期209-211,共3页 Chinese Journal of Current Advances in General Surgery
基金 重庆市卫生局科研基金资助项目(渝卫科教[2001]012072)
关键词 移植 同种 动脉 金属蛋白酶组织抑制剂 基质溶解素1 Transplantation,homlolgous Arteries Tissue inhibitor of metalloproteinase-3 Stromelysin 1
  • 相关文献

参考文献5

  • 1Brew K,Dinakarpandian D,and Nagase H.Tissue inhibitors of metalloproteinases:evolution,structure and function[J].Biochim Biophys Acta,2000,1477:267-283.
  • 2Hayry P.Chronic rejection:risk factors,regulation,and possible sites of therapeutic intervention[J].Transplant Proc,1980,30:2407-2410.
  • 3Solomon A,Li DQ ,Lee SB,et al.Regulation of collagenase,stromelysin,and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines[J].Invest Ophthalmol Vis Sci,2000,41:2154-2163.
  • 4Legare JF,Issekutz T,Lee TDG,et al.CD8+T Lymphocytes Mediate Destruction of the Vascular Media in a Model of Chronic Rejection[J].Am J Pathol,2000,157:859-865.
  • 5Farina AR,Coppa A,Tiberio A,et al.Transforming growth factor-betal enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulation urokinase activity [J].Int J Cancer,1998,75:721-730.

同被引文献8

  • 1李生伟,甘霖,龚建平,彭勇,丁雄,殷樱.TIMP-3质粒脂质复合体防止移植物慢性排斥反应的实验研究[J].中国现代普通外科进展,2005,8(3):164-168. 被引量:1
  • 2Pepper MS.Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2001;21 (2):1104-1110.
  • 3Baker AH,Zaltsman AB,George S J,et al.Divergent Effects of Tissue Inhibitor of Metalloproteinase-1,-2,or -3Overexpression on Rat Vascular Smooth Muscle Cell Invasion,Proliferation,and Death In Vitro[J].J Clin Invest,1998;101(5):1478-1487.
  • 4Deryugina EI,Soroceanu Land Strongin AY.Up-Regulation of Vascular Endothelial Growth Factor by Membrane-type 1Matrix Metalloproteinase Stimulates Human Glioma Xenograft Growth and Angiogenesis[J].Cancer Research,2002;62(11):580-588.
  • 5DeClerck YA,Mercurio AM,Stack MS,et al.Proteases,Extracellular Matrix,and Cancer[J].American Journal of Pathology,2004; 164(7):1131-1139.
  • 6Qi JH,Anand-Apte B.Tissue Inhibitor of Metalloproteinase-3(TIMP-3) Suppresses VEGF Receptor-2 Mediated Signaling Independent of Metalloproteinase Inhibition[J].Invest Ophthalmol Vis Sci,2002;43(18):2753-2761.
  • 7Bond M,Murphy G,Bennett MR,et al.Tissue Inhibitor of Metalloproteinase-3 Induces a Fas-associated Death Domain-dependent Type Ⅱ Apoptotic Pathway[J].Biol.Chem,2002;277(3):13787-13795.
  • 8彭东涛,苟欣,何梓铭.膀胱癌组织中MMP9、MMP2与PCNA及临床指标的研究[J].重庆医科大学学报,2003,28(4):467-469. 被引量:5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部